Comparative Characterization of Cultured Human Term Amnion Epithelial and Mesenchymal Stromal Cells for Application in Cell Therapy

Autor: Roland Zimmermann, Ajit S. Mallik, Steffen M. Zeisberger, Grozdana Bilic, Andreas H. Zisch
Přispěvatelé: University of Zurich, Bilic, G
Jazyk: angličtina
Rok vydání: 2008
Předmět:
Pathology
medicine.medical_specialty
2747 Transplantation
Cell Survival
Biomedical Engineering
Cell Culture Techniques
Cell- and Tissue-Based Therapy
2204 Biomedical Engineering
lcsh:Medicine
610 Medicine & health
Stem cell factor
Biology
Mesenchymal Stem Cell Transplantation
1307 Cell Biology
Andrology
medicine
Humans
CD90
Telomerase reverse transcriptase
Amnion
RNA
Messenger

Progenitor cell
10026 Clinic for Obstetrics
Cell Shape
Cells
Cultured

Cell Proliferation
Transplantation
Stem Cell Factor
Reverse Transcriptase Polymerase Chain Reaction
Mesenchymal stem cell
lcsh:R
Cell Differentiation
Epithelial Cells
Mesenchymal Stem Cells
Cell Biology
Embryonic stem cell
medicine.anatomical_structure
10076 Center for Integrative Human Physiology
Antigens
Surface

embryonic structures
cardiovascular system
570 Life sciences
biology
Stromal Cells
Octamer Transcription Factor-3
Biomarkers
Zdroj: Cell Transplantation, Vol 17 (2008)
ISSN: 1555-3892
0963-6897
Popis: Emerging evidence suggests human amnion tissue as a valuable source of two distinct types of pluripotent cells, amnion epithelial cells (hAECs) and mesenchymal stromal cells (hAMSCs), for applications in cell replacement therapy. For some approaches, it may be necessary to culture and differentiate these cells before they can be transplanted. No systematic attempt has been yet made to determine the quantity and quality of amnion cells after isolation and culture. We looked at amnion cell isolates from 27 term placentas. Following our optimized protocol, primary yields were 6.3 × 106 hAECs and 1.7 × 106 hAMSCs per gram amnion. All 27 cases gave vital cultures of hAMSCs, while one third of cases (9 of 27) failed to give adherent cultures of hAECs. Primary cultures contained significantly more proliferating than apoptotic cells (hAECs: 16.4% vs. 4.0%; hAMSCs: 9.5% vs. 2.4%). Neither hAECs nor hAMSCs were clonogenic. They showed slow proliferation that almost stopped beyond passage 5. Microscopic follow-up revealed that hAEC morphology gradually changed towards mesenchymal phenotype over several passages. Flow cytometric characterization of primary cultures showed expression of mesenchymal progenitor markers CD73, CD90, CD105, and CD166, as well as the embryonic stem cell markers SSEA-3 and -4 on both amnion cell types. These profiles were grossly maintained in secondary cultures. Reverse transcriptase-PCR analysis exhibited transcripts of Oct-3/4 and stem cell factor in primary and secondary cultures of all cases, but no telomerase reverse transcriptase. Immunocytochemistry confirmed translation into Oct-3/4 protein in part of hAEC cultures, but not in hAMSCs. Further, both amnion cell types stained for CD90 and SSEA-4. Osteogenic induction studies with amnion cells from four cases showed significantly stronger differentiation of hAECs than hAMSCs; this capacity to differentiate greatly varied between cases. In conclusion, hAECs and hAMSCs in culture exhibit and maintain a similar marker profile of mesenchymal progenitors. hAECs were found as a less reliable source than hAMSCs and altered morphology during subculture.
Databáze: OpenAIRE